Regular TSH testing 6 to 8 weeks after starting semaglutide and after significant weight loss helps your provider determine whether your dose requires fine-tuning
References: Nslund E, Gutniak M, Skogar S, Rssner S, Hellstrm PM
Omzo's published disclosures describe this separation clearly - which is what informed buyers should look for when evaluating any compounded GLP-1 program
Coverage for Wegovy varies depending on your insurance provider and plan

You should contact your GP or prescribing clinician if you experience: Persistent or severe nausea and vomiting that prevents adequate fluid or food intake, as this may lead to dehydration Severe or persistent abdominal pain , particularly if localised to the upper abdomen, which could indicate pancreatitis (a rare but serious adverse effect of GLP-1 agonists) Unexplained weight loss beyond what is expected from the medication's therapeutic effect Changes in bowel habit lasting more than a few weeks, including persistent diarrhoea or new-onset constipation Signs of malabsorption , such as pale, floating, foul-smelling stools (steatorrhoea), which may indicate pancreatic insufficiency Symptoms that significantly impair quality of life or prevent you from continuing your medication Right upper quadrant pain, fever, or yellowing of the skin/eyes , which could indicate gallbladder disease (a reported risk with GLP-1 medications) [16] [17] Seek urgent medical attention via NHS 111 or 999 if you develop severe, persistent upper abdominal pain, especially with vomiting

Trustpilot reviews praise specific reps by name, which is the strongest signal of consistent service in the lineup